We are live on ! Find out more
AE

Axon Enterprise Portfolio holdings

AUM $19.1M
1-Year Est. Return 8.75%
This Fund
S&P 500
This Quarter Est. Return
-2.7%
1 Year Est. Return
-8.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$27.2M
AUM Growth
-$41M
Cap. Flow
-$39M
Cap. Flow %
-143.19%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CLBT icon
Cellebrite
CLBT
+$39M

Sector Composition

Rank Sector Weight
1 Technology 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBT icon
1
Cellebrite
CLBT
$3.01B
$27.2M 100%
1,509,341
-2,170,034
-59% -$39M

Similar funds

Axon Enterprise's Q4 2025 Portfolio in Review

As of Q4 2025, Axon Enterprise held 1 position worth $27.2M, down 60% from $68.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Axon Enterprise withdrew a net $39M in Q4 2025, reducing 1 holding. Its largest reduction was Cellebrite, cutting an estimated $39M.

By sector, the portfolio is most concentrated in Technology at 100% of assets, unchanged from a quarter earlier.

  • Axon Enterprise's biggest Q4 2025 reduction was Cellebrite, cutting an estimated $39M.
  • Axon Enterprise's ten largest holdings make up 100% of its $27.2M portfolio in Q4 2025.
  • Axon Enterprise opened 0 new positions and closed 0 in Q4 2025.
  • Axon Enterprise's portfolio value fell 60% quarter-over-quarter to $27.2M.

Based on Axon Enterprise's 13F filing for Q4 2025, filed 17 Feb 2026.